Improving Osimertinib Exposure and Cost-effectiveness Using Pharmacokinetic Boosting With Cobicistat

Clinical trial NCT05748093 · RECRUITING

Trial details

NCT number: NCT05748093
Sponsor: Maastricht University Medical Center
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer

Start date: 2024-04-01
Primary completion: 2026-06-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.